Form Type: 4

SEC EDGAR Link
Accession Number:0001126234-21-000088
Date:2021-06-01
Issuer: LUMOS PHARMA, INC. ((LUMO))
Original Submission Date:

Reporting Person:

SCHUCHART AARON
4200 MARATHON BLVD
SUITE 200 AUSTIN, TX 78756

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 10.13 2021-06-01 deemed execution date A 7,805 (a) 2031-05-31 common stock 7,805 $10.13 7,805 direct
Footnotes
IDfootnote
f1 grant to the reporting person of a stock option under the issuer's 2009 equity incentive plan (the "plan"). the option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on july 1, 2021, provided that at the relevant vesting dates the reporting person's continuous service to the issuer has not been terminated as defined in or as determined under the plan. the option expires ten years after the date of grant.

Elevate your investments